Active, Not Recruiting
Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants
NCT05469360
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- Novartis Investigative Site Kuopio, Finland
- Novartis Investigative Site Turku, Finland
- Novartis Investigative Site Lille, France
- Novartis Investigative Site Paris, France